We investigated the deposition of Bb and CFB in renal specimens of patients with DN (n = 21), patients with minimal change disease (MCD; n = 10), and HCs (n = 10) by immunohistochemical staining to investigate complement AP activation in kidneys. This evidence concerns the gene CFB and liver dysplastic nodule.